Physician

Maria C Mascolo, MD

According to 2025 Medicare claims, Maria Mascolo, MD (NPI: 1194793042) practices pulmonary disease in the Savannah, GA market, with the plurality of this provider's patient population coming from Effingham, GA. This provider's primary affiliated billing organization is SOUTHEAST LUNG & CRITICAL CARE SPECIALISTS, P.C. (NPI: 1740244276; TIN: 58-2362019) and primary practice location at 31326-5131.

Mascolo's data goes back to 2015 and runs through 2024. For example, in 2024, this provider had 800 traditional Medicare patients, billed 5,978 HCPCS/CPT codes, and received $257,406 in Medicare payments. The top billing code was 99214 (Established patient office or other outpatient visit with moderate level of decision making, if using time, 30 minutes or more). Part D data shows 3,277 prescription claims across 596 beneficiaries totaling $1,278,254 in drug costs, led by Trelegy Ellipta (Fluticasone/Umeclidin/Vilanter). DME data shows 4,262 claims. Open Payments data shows 432 records totaling $504,731. You can download detailed data with all billing codes (2015-2024). For more recent data, please contact us.

Over the past 10 years, this provider's Medicare Part B carrier billing has changed little. Concurrently, Part D prescription costs did not follow a clear longitudinal pattern. For DME billing, reported payments changed little.

Part B Carrier Billing Trend

Medicare payment trend, with N of patients and claim lines in the table.

Year	Patients	Clm Lines	Payment
2015	901	7,047	$276,389
2016	890	7,785	$278,899
2017	887	9,591	$320,498
2018	836	9,296	$296,666
2019	899	8,189	$290,735
2020	875	5,072	$213,493
2021	862	4,208	$221,818
2022	842	4,578	$217,992
2023	833	4,985	$224,830
2024	800	5,978	$257,406

Part D Events Trend

Drug cost trend, with N of patients and prescription claims in the table.

Year	Patients	Claims	Drug Cost
2015	415	3,460	$786,021
2016	443	3,714	$1,188,930
2017	476	3,924	$1,052,180
2018	515	4,301	$1,120,609
2019	568	4,372	$1,549,741
2020	618	4,697	$1,772,961
2021	602	4,328	$1,747,255
2022	578	3,449	$1,768,673
2023	587	2,859	$1,272,882
2024	596	3,277	$1,278,254

DME Billing Trend

Medicare payment trend, with N of patients and DME claim records in the table.

Year	Patients	Claims	Payment
2015	1,514	4,393	$303,936
2016	1,566	4,580	$237,498
2017	2,160	5,988	$250,019
2018	2,282	6,590	$274,583
2019	2,081	5,504	$246,591
2020	2,216	6,211	$310,215
2021	2,036	5,471	$302,443
2022	1,953	5,050	$301,094
2023	1,907	5,007	$312,738
2024	1,549	4,262	$224,534

* / # = suppressed by CMS; 0 = reported zero; N/R = not reported or blank.

Top 5 Part B carrier billing codes in 2024

By total payments.

Code	Description	Patients	Clm Lines	Total Payment
99214	Established patient office or other outpatient visit with moderate level of decision making, if using time, 30 minutes or more	467	946	$85
99213	Established patient office or other outpatient visit with low level od decision making, if using time, 20 minutes or more	281	360	$58
94729	Test to examine how well the lungs exchange gases	277	278	$35
94727	Test to determine lung volumes using gas dilution or washout	278	279	$28
94010	Test to measure expiratory airflow and volume	366	525	$18

Top 5 Part D drugs in 2024

By total drug costs.

Drug	Generic	Claims	Total Day Supply	Total Drug Cost
Trelegy Ellipta	Fluticasone/Umeclidin/Vilanter	338	15,090	$319,318
Prolastin C	Alpha-1-Proteinase Inhibitor	15	385	$189,194
Breztri Aerosphere	Budesonide/Glycopyr/Formoterol	112	4,860	$101,270
Fasenra Pen	Benralizumab	13	728	$74,212
Breo Ellipta	Fluticasone/Vilanterol	88	4,170	$53,988

Top 5 DME services in 2024

By Total Medicare Payment Amount.

HCPCS Code	HCPCS Description	Supplier Rental Indicator	Total Supplier Beneficiaries	Total Supplier Claims	Total Medicare Payment Amount
E1390	Oxygen concentrator, single delivery port, capable of delivering 85 percent or greater oxygen concentration at the prescribed flow rate	Y	70	488	$37,370
A7031	Face mask interface, replacement for full face mask, each	N	84	195	$17,851
E0483	High frequency chest wall oscillation system, with full anterior and/or posterior thoracic region receiving simultaneous external oscillation, includes all accessories and supplies, each	Y	N/R	19	$17,628
E0466	Home ventilator, any type, used with non-invasive interface, (e.g., mask, chest shell)	Y	N/R	17	$17,077
A7030	Full face mask used with positive airway pressure device, each	N	89	188	$15,366

Open Payments Summary in 2024

Category	Definition	Records	Total Reported Amount	Top Related Entity
General Payments	Reported payment or transfer-of-value amount.	238	$90,911	AstraZeneca Pharmaceuticals LP
Research Payments	Reported research-related payment or transfer-of-value amount.	194	$413,820	SANOFI PASTEUR INC.
Ownership / Investment Interests	Reported value of ownership or investment interests.	0	$0	N/R

Explore More Providers

FAQ

What Medicare data is available for Maria C. Mascolo, MD?

Tedicare shows public-source Medicare data for Maria C. Mascolo, MD (NPI 1194793042), including provider identity, specialty, market context, Medicare Part B activity, Part D prescribing, DME records, Open Payments where available, billing organization details, and ACO affiliation signals where available. Profile data covers 2015-2024, with current attribution based on 2025 claims where available.

Does Maria C. Mascolo, MD have ACO affiliation data?

No ACO affiliation record is shown in the available Tedicare data for this profile.

What billing organization is linked to Maria C. Mascolo, MD?

Maria C. Mascolo, MD is linked to SOUTHEAST LUNG & CRITICAL CARE SPECIALISTS, P.C. (billing NPI 1740244276) in the available physician profile data.

Does Maria C. Mascolo, MD have Open Payments data?

Maria C. Mascolo, MD has 432 connected Open Payments records in the available 2024 summary data.

Can I download physician-level Medicare data from Tedicare?

Yes. Tedicare provides sample physician export data and paid custom physician data exports for research, planning, outreach, and market analysis. Exports can include physician profile fields, market and specialty context, billing organization details, ACO affiliation signals where available, and Medicare utilization data.